Infective endocarditis

New England Journal of Medicine

Volumn 369, Issue 8, 2013, Pages 784-785

  Nesseler, Nicolas ^a   Launey, Yoann ^a   Malled́ant, Yannick ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; DRUG SUBSTITUTION; HEART VALVE REPLACEMENT; HUMAN; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTHETIC VALVE ENDOCARDITIS;

EID: 84882753547     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1307282     Document Type: Letter

References (4)

1. Hoen B, Duval X. Infective endocarditis. N Engl J Med 2013;368:1425-33. [Erratum, N Engl J Med 2013;368:2536.]
2. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009;30:2369-413.
3. Fadel HJ, Tleyjeh IM, Steckelberg JM, Wilson WR, Baddour LM. Evaluation of antibiotic therapy following valve replacement for native valve endocarditis. Eur J Clin Microbiol Infect Dis 2009;28:1395-8.
4. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111(23):e394-434. [Errata, Circulation 2005;112:2373, 2007;115(15):e408, 2007;116(21):e547, 2008;118(12):e497.]